ReviewCNS drugs2017
New Formulations of Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder: Pharmacokinetics, Efficacy, and Tolerability.
Samuele Cortese et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this paperpooled ittrialcites it